Form 4: BioLife Solutions Executive Sells 10,000 Shares Under 10b5-1 Trading Plan

Todd Berard, Chief Marketing Officer of BioLife Solutions, sold 10,000 shares of common stock at a price of $15.67 per share on April 15, 2024, under a pre-arranged trading plan.

Summary

• On April 15, 2024, Todd Berard, the Chief Marketing Officer of BioLife Solutions Inc. (BLFS), sold 10,000 shares of the company's common stock.
• The sale was executed at a price of $15.67 per share.
• The transaction was conducted under a Rule 10b5-1(c) trading plan adopted on December 15, 2023.
• Following the transaction, Berard directly owns 129,644 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting an executive's stock sale. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

Executive stock sales are a common occurrence and are often part of pre-planned diversification strategies. The use of a 10b5-1 trading plan allows insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some investors, potentially leading to a slight decrease in stock price, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates